在渐进的超核性麻中执行 anosognosia 与帕金森病相比
L Ye1, L Seidler1, D Chemodanow1
1Department of Neurology, Hannover Medical School, Hannover, Germany.
Frontiers in neurology
|February 18, 2026
概括
患有渐进性超核性 (PSP) 的患者表现出比帕金森病更大的执行性无意识症.
科学领域:
- 神经科学是一个神经科学.
- 认知心理学 认知心理学
- 神经学 神经学
背景情况:
- 执行功能缺陷在帕金森病 (PD) 和渐进性上核性麻 (PSP) 中很普遍.
- 执行性无意识症,即无法识别或报告执行功能的缺陷,会影响这些疾病的一些患者.
- 了解执行性无意识症对于精确评估和治疗神经退行性疾病至关重要.
研究的目的:
- 在被诊断患有PSP和PD的患者中比较分析执行 anosognosia.
- 评估客观执行功能评估与主观患者/告知者报告之间的差异.
主要方法:
- 执行功能的客观神经心理评估 (ONA-CEF) 与患者和告知者报告的尺度 (DEX-R,AAPI-CP) 的比较.
- 计算的差异指数来量化客观绩效和主观意识之间的差距.
- 利用语义/语音语言流利性和威斯康星州卡片排序测试ONA-CEF的子分数.
主要成果:
- 与PD患者相比,PSP患者表现出明显更大的执行性无意识 (较大的负差异).
- 举报人报告部分减少了差异,但并没有消除PSP中报告不足的情况.
- 患者报告的困难 (DEX-R) 与抑郁症状相关,而不是客观执行功能.
结论:
- 执行 anosognosia 作为PSP的标记,强调在临床试验中客观评估的必要性.
- 在PSP中,患者报告的结果受到情绪的影响,而不是实际障碍,从而挑战了他们的有效性.
- 客观的神经心理测试对于在PSP和类似的神经疾病中准确评估执行功能至关重要.
相关概念视频
Parkinson's Disease: Overview
2.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.1K
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Neural Regulation
43.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.6K
Prosopagnosia
876
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
876
Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
Visual Agnosia
1.3K
Visual agnosia is a condition characterized by the inability to recognize visually presented objects despite having normal vision. For instance, a person with visual agnosia can describe the shape and color of an object but cannot identify or name it. This impairment does not affect their visual field, acuity, color vision, brightness discrimination, language, or memory. An example of this condition in a social setting is someone at a dinner party asking for "that silver thing with a round...
1.3K


